Filing Details

Accession Number:
0001209191-23-016866
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-07 17:19:37
Reporting Period:
2023-02-28
Accepted Time:
2023-03-07 17:19:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1357874 Precision Biosciences Inc DTIL Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779581 Dario Scimeca C/O Precision Biosciences, Inc.
302 E Pettigrew Street, Suite A-100
Durham NC 27701
General Counsel And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-28 2,163 $0.95 34,677 No 5 A Direct
Common Stock Acquisiton 2023-03-03 27,558 $0.00 62,235 No 4 M Direct
Common Stock Disposition 2023-03-06 12,172 $1.07 50,063 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-03-03 27,558 $0.00 27,558 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,101 No 4 M Direct
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.
  2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  3. The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  4. On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.